CN110256372A - A kind of Linezolid impurity and preparation method - Google Patents
A kind of Linezolid impurity and preparation method Download PDFInfo
- Publication number
- CN110256372A CN110256372A CN201910639379.3A CN201910639379A CN110256372A CN 110256372 A CN110256372 A CN 110256372A CN 201910639379 A CN201910639379 A CN 201910639379A CN 110256372 A CN110256372 A CN 110256372A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- preparation
- tert
- butyl alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910639379.3A CN110256372A (en) | 2019-07-16 | 2019-07-16 | A kind of Linezolid impurity and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910639379.3A CN110256372A (en) | 2019-07-16 | 2019-07-16 | A kind of Linezolid impurity and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110256372A true CN110256372A (en) | 2019-09-20 |
Family
ID=67926378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910639379.3A Pending CN110256372A (en) | 2019-07-16 | 2019-07-16 | A kind of Linezolid impurity and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110256372A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113979961A (en) * | 2021-11-08 | 2022-01-28 | 湖南增达生物科技有限公司 | Linezolid impurity and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007064818A1 (en) * | 2005-12-01 | 2007-06-07 | Teva Pharmaceutical Industries Ltd. | Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
CN107573297A (en) * | 2017-08-31 | 2018-01-12 | 桂林南药股份有限公司 | A kind of preparation method of the acidic hydrolysis impurity of Linezolid |
-
2019
- 2019-07-16 CN CN201910639379.3A patent/CN110256372A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007064818A1 (en) * | 2005-12-01 | 2007-06-07 | Teva Pharmaceutical Industries Ltd. | Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
CN107573297A (en) * | 2017-08-31 | 2018-01-12 | 桂林南药股份有限公司 | A kind of preparation method of the acidic hydrolysis impurity of Linezolid |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113979961A (en) * | 2021-11-08 | 2022-01-28 | 湖南增达生物科技有限公司 | Linezolid impurity and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111377983B (en) | Preparation method of beta-nicotinamide mononucleotide | |
CN101880290B (en) | Preparation method of cefamandole nafate | |
CN115011661B (en) | Synthesis method of 3 beta-ursodeoxycholic acid | |
CN113150004A (en) | Compound A3, preparation method thereof and application thereof as pranoprofen impurity | |
CN110256372A (en) | A kind of Linezolid impurity and preparation method | |
CN109438336A (en) | A kind of preparation method of Rui Gefeini hydrate | |
CN106117183B (en) | A kind of refining methd of high-purity benzene sulphur bepotastine | |
US20230002312A1 (en) | A continuous flow process for the synthesis of hydroxamic acid | |
CN111253309A (en) | Acridinone fluorescent amine compound labeling reagent and synthesis method and application thereof | |
CN103333180B (en) | Preparation method of aspoxicillin | |
CN106636241B (en) | Method for preparing esmollin intermediate by enzyme method | |
CN101735164A (en) | Method for researching and controlling impurity F in valsartan | |
CN113024411B (en) | Preparation method of tralkoxydim | |
CN113804805A (en) | Pregabalin intermediate impurity compound II and preparation method thereof | |
CN104230955B (en) | A kind of preparation method to the acid of hydroxyl penicillin V and salt thereof | |
CN110105371B (en) | Impurities in doladazole bulk drug and preparation method thereof | |
CN113024405A (en) | Novel lacosamide impurity and preparation method and application thereof | |
CN113121492A (en) | Vilandiolo intermediate, preparation method and application thereof | |
CN110759941A (en) | Preparation method of D-gluconic acid-gamma-lactone and intermediate thereof | |
CN115232019B (en) | Synthesis method of 3-acetamido benzotrifluoride compound | |
KR100509737B1 (en) | Method for crystallization of 7-aminocephalosporanic acid | |
CN110483505A (en) | 2- phenylimidazole [1,2-a] pyridine -3- nitrile replaced using DMF and ammonium iodide as cyanylation agent building | |
CN104450851B (en) | A kind of preparation method for removing acetyl cefathiamidine | |
CN114163371B (en) | Meropenem side chain optical isomer, preparation method and application thereof, and meropenem side chain impurity detection method | |
CN111454214B (en) | Synthetic method of 2-methoxy-1-pyrimidineethylamine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210928 Address after: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Applicant after: Dijia Pharmaceutical Group Co.,Ltd. Applicant after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 266440 No.268, Tianrun Road, Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Applicant before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Effective date of registration: 20210928 Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Applicant after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Applicant before: Dijia Pharmaceutical Group Co.,Ltd. Applicant before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Applicant after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Applicant before: Dijia Pharmaceutical Group Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190920 |